Back to News
Market Impact: 0.08
International Association for the Study of Lung Cancer Launches Complimentary IASLC Full Membership for Eligible Countries to Expand Worldwide Participation in Thoracic Oncology
Source: PR Newswire
Healthcare & Biotech
The International Association for the Study of Lung Cancer announced a full-membership initiative removing financial barriers for clinicians, researchers and health professionals in eligible low- and lower-middle-income countries. The program is intended to expand access to the association's professional and research network, but the announcement has limited direct public-market implications.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- Roche’s collaborator MediLink announces phase III data for Tam-Peli showing significantly improved overall survival in Chinese patient population with relapsed small-cell lung cancer
- ‘The family paid the price’: India’s deadly online gambling crisis
- Outlook Therapeutics at H.C. Wainwright: launch hinges on access
- SeaStar Medical at H.C. Wainwright: adult trial looms over small cap
- AnaptysBio earnings missed by $0.34, revenue fell short of estimates
- DR Congo’s worst Ebola epidemic ever passes 7,000 cases